Fisher Scientific launches global RNA study

October 13, 2005

NH Business Review Staff,

Hampton-based Fisher Scientific has launched a global initiative aimed at developing drugs based on studying RNA, with its first meeting taking place in Boston on Oct. 17-18.

The firm’s Colorado subsidiary, Dharmacon Inc. — a business unit of Fisher Biosciences, another Fisher Scientific subsidiary — announced late last week that it has formed the Genome-Wide RNAi Global Initiative, an alliance of leading international biomedical research centers.

RNA is directly responsible for the manufacturing of proteins, many of which perform crucial functions of the body. In the wake of the effort to map the human DNA genome, there has been a similar effort to do the same with RNA. The DNA studies have increased scientists’ ability to understand disease mechanism and develop new drugs.

Members of the initiative include The London Research Institute, the German Cancer Research Center, the University of Nebraska Medical Center, Netherlands Cancer Institute, Yale University and others. – BOB SANDERS

Categories: News

More news from NHBR:

What employers need to know about new workplace rule interpretation

NLRA guidance contains a more employer-friendly view

Digital Identity Security And Protection Strategy Latch

The compliance trap in lead-generation services

This article outlines key considerations for U.S.-based companies that offer lead-generation services — i.e., selling lists of contact information for use in marketing or direct outreach.

NHBR About Town: Week of April 10, 2026

Business and event happenings around the state of NH

The Latest: Week of April 10, 2026

The Latest is a roundup of the comings and goings of the movers and shakers in NH's business community

Ask the Experts: Planning is paramount for wills, trusts and estates

Planning for the future, particularly as a business owner, requires more than a simple will. Our panelist of professionals explore the fundamentals of estate planning, from choosing between wills and trusts to preparing for incapacity and business succession. Their insights highlight how thoughtful planning can protect assets, reduce legal complications, maximize financial benefits and ensure your wishes are carried out for both family and business interests.

NH WARN: what employers need to know about layoff notices

Workforce reductions are never easy. Whether driven by economic uncertainty, industry shifts or strategic restructuring, layoffs can be some of the most difficult decisions business leaders face. At the same time, workforce reductions carry legal obligations that are easy to overlook, particularly under state law. In New Hampshire, one of the most misunderstood of those obligations is the state’s WARN Act.

New administrator of YDC fund confirmed

Nearly nine months after a controversial change to the Youth Development Center abuse claims process pushed the administrator from his job and stalled the proceedings for survivors, the fund now has a new leader.

(Opinion) Opportunity Zones 2.0: Other states are getting ready, is New Hampshire?

With the permanent passage of the One Big Beautiful Bill Act this past summer, Opportunity Zones (OZ) are being reset, and with it, an opportunity for New Hampshire to shape what comes next. The question is whether we’re ready and whether municipalities, developers and state leaders are aligned to act.

(Opinion) Businesses are part of the village that stops child abuse and neglect

April is National Child Abuse Prevention Month. New Hampshire Children’s Trust (NHCT), in collaboration with our national partner, Prevent Child Abuse America (PCAA), uses this month as an opportunity to spread awareness about ways to stop child abuse and neglect before it happens.